Technical Analysis for GH - Guardant Health, Inc.

Grade Last Price % Change Price Change
grade A 52.91 4.94% 2.49
GH closed up 4.94 percent on Thursday, February 21, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical GH trend table...

Date Alert Name Type % Chg
Feb 21 New 52 Week Closing High Bullish 0.00%
Feb 21 New Uptrend Bullish 0.00%
Feb 21 Upper Bollinger Band Walk Strength 0.00%
Feb 21 Wide Bands Range Expansion 0.00%
Feb 21 Above Upper BB Strength 0.00%
Feb 21 Overbought Stochastic Strength 0.00%
Feb 21 Upper Bollinger Band Touch Strength 0.00%
Feb 20 Calm After Storm Range Contraction 4.94%
Feb 20 Upper Bollinger Band Walk Strength 4.94%
Feb 20 Multiple of Ten Bullish Other 4.94%

Older signals for GH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Its Guardant Health Oncology Platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. In pursuit of its goal to manage cancer across all stages of the disease, Guardant Health has launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2, respectively. Since its launch in 2014, Guardant360 has been used by more than 5,000 oncologists, over 40 biopharmaceutical companies and all 27 of the National Comprehensive Cancer Network centers.
Medicine Biopharmaceutical Cancer Medical Specialties Disease Oncology Lower Healthcare Costs
Is GH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 54.32
52 Week Low 27.04
Average Volume 465,963
200-Day Moving Average 0.0
50-Day Moving Average 40.4894
20-Day Moving Average 43.194
10-Day Moving Average 45.991
Average True Range 2.6382
ADX 25.75
+DI 41.4228
-DI 8.9236
Chandelier Exit (Long, 3 ATRs ) 46.4054
Chandelier Exit (Short, 3 ATRs ) 46.6246
Upper Bollinger Band 52.1503
Lower Bollinger Band 34.2377
Percent B (%b) 1.04
BandWidth 41.470112
MACD Line 2.9598
MACD Signal Line 1.7786
MACD Histogram 1.1812
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 56.65
Resistance 3 (R3) 56.23 54.58 56.02
Resistance 2 (R2) 54.58 53.63 54.78 55.81
Resistance 1 (R1) 53.74 53.04 54.16 54.16 55.61
Pivot Point 52.09 52.09 52.30 52.29 52.09
Support 1 (S1) 51.25 51.14 51.67 51.67 50.21
Support 2 (S2) 49.60 50.55 49.80 50.01
Support 3 (S3) 48.76 49.60 49.80
Support 4 (S4) 49.18